Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D03FOP
|
|||
| Former ID |
DNCL002368
|
|||
| Drug Name |
AMG 319
|
|||
| Indication | Hematologic tumour [ICD-11: 2B33.Y] | Phase 1 | [1] | |
| Myeloid leukaemia [ICD-11: 2B33.1] | Phase 1 | [1] | ||
| Company |
Amgen Thousand
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C21H16FN7
|
|||
| Canonical SMILES |
CC(C1=C(N=C2C=C(C=CC2=C1)F)C3=CC=CC=N3)NC4=NC=NC5=C4NC=N5
|
|||
| InChI |
1S/C21H16FN7/c1-12(28-21-19-20(25-10-24-19)26-11-27-21)15-8-13-5-6-14(22)9-17(13)29-18(15)16-4-2-3-7-23-16/h2-12H,1H3,(H2,24,25,26,27,28)/t12-/m0/s1
|
|||
| InChIKey |
KWRYMZHCQIOOEB-LBPRGKRZSA-N
|
|||
| CAS Number |
CAS 1608125-21-8
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01300026) AMG 319 Lymphoid Malignancy FIH. U.S. National Institutes of Health. | |||
| REF 2 | National Cancer Institute Drug Dictionary (drug id 696292). | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.